Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
---|
07/27/1993 | CA1320795C Process for recovery of glycopeptidic antibiotics |
07/27/1993 | CA1320718C Chromatographic material |
07/22/1993 | WO1993014465A1 Prediction of the conformation and stability of macromolecular structures |
07/22/1993 | WO1993014220A1 Antibodies recognizing the fourth immunoglobulin-like domain of vcam1 |
07/22/1993 | WO1993014207A1 Chimeric immunogens |
07/22/1993 | WO1993014202A1 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
07/22/1993 | WO1993014114A1 Peptide linkage unit comprising methylene phosphinic acid |
07/22/1993 | WO1993014113A1 Peptides with tachykinin antagonist activity |
07/22/1993 | WO1993014108A1 Selection of binding-molecules |
07/22/1993 | WO1993013789A1 Hemoregulatory peptides |
07/22/1993 | WO1993007262A3 Purified chitin deacetylase |
07/22/1993 | WO1993007168A3 Protein chromatography system |
07/22/1993 | CA2128016A1 Selection of binding-molecules |
07/22/1993 | CA2127688A1 Hemoregulatory peptides |
07/22/1993 | CA2127532A1 Antibodies recognizing the fourth immunoglobulin-like domain of vcam1 |
07/22/1993 | CA2127295A1 Peptide linkage unit comprising methylene phosphinic acid |
07/21/1993 | EP0551916A2 Process for stabilisation of proteins |
07/21/1993 | EP0551553A1 Process for refining zein |
07/21/1993 | EP0551460A1 HCV peptide-antigens and a method of testing for the hepatitis C virus (HCV) |
07/21/1993 | EP0551440A1 Design of bioactive peptides based on immunoglobulin structure |
07/21/1993 | EP0551304A1 Fungicidally active compounds |
07/20/1993 | US5229498 Method of cleansing a protein from multivalent metal ions bound thereto |
07/20/1993 | US5229495 Transforming growth factor |
07/20/1993 | US5229272 Catalytic antibody components |
07/14/1993 | EP0551084A2 Human antithrombin-III preparation |
07/14/1993 | EP0550629A1 Metal ion mediated receptor binding of polypeptide hormones |
07/14/1993 | EP0550561A1 Purification of cytokeratin fragments |
07/14/1993 | EP0550485A1 DERIVATIVES OF gp160 AND VACCINES BASED ON gp160 OR A DERIVATIVE THEREOF, CONTAINING AN ADJUVANT |
07/13/1993 | US5227309 C-terminal peptide sequencing method |
07/13/1993 | CA1320160C Monoclonal antibodies against ifn-omega, processes for preparing them and their use in the purification and detection of ifn-omega |
07/08/1993 | WO1993014110A1 Method for isolating biomolecules with linear polymers |
07/08/1993 | WO1993013421A1 Immunochemical detection of in vivo advanced glycosylation endproducts |
07/08/1993 | WO1993013211A1 Expression and purification of recombinant soluble tissue factor |
07/08/1993 | WO1993013209A1 Expression signal-peptide-free staphylokinases |
07/08/1993 | WO1993013132A1 Novel megakaryocyte amplifier |
07/08/1993 | WO1993013131A1 Process for producing protein-synthetic polymer composite and said composite produced thereby |
07/08/1993 | WO1993013126A1 Peptide compounds having therapeutic activity |
07/08/1993 | WO1993013125A1 Protein production |
07/08/1993 | WO1993013089A1 Macrocyclic polyether carboxylic acids |
07/08/1993 | WO1993012667A1 Purification of zein from corn gluten meal |
07/08/1993 | DE4240545A1 Peptide(s) prepn. using proteolytic enzymes - carried out in the absence of solvents, using substance contg. water of crystallisation to provide necessary water |
07/08/1993 | CA2126668A1 Purification of zein from corn gluten meal |
07/08/1993 | CA2126236A1 Peptide compounds having therapeutic activity |
07/08/1993 | CA2126209A1 Immunochemical detection of in vivo advanced glycosylation endproducts |
07/08/1993 | CA2125853A1 Protein production |
07/08/1993 | CA2104772A1 Method for isolating biomolecules with linear polymers |
07/07/1993 | EP0549915A1 New synthetic isohirudines with enhanced stability |
07/07/1993 | EP0549778A1 Method of stabilizing proteins during optical tests |
07/07/1993 | EP0549752A1 Protein sequencing |
07/07/1993 | EP0549711A1 Natural killer stimulatory factor |
07/07/1993 | CN1073978A Novel synthetic isohirudins with improved stability |
07/07/1993 | CN1073977A Recombinant gene coding for human alpha interferon and expression vector thereof, ETC. |
07/06/1993 | US5225543 Receptors method for purification of g protein-linked |
07/06/1993 | US5225533 General method for producing and selecting peptides with specific properties |
07/06/1993 | US5225532 Symmetrical bipeptides containing a polyalkylene glycol residue, method of preparation and use in the assay of proteases |
07/06/1993 | US5225529 Synthetic amphiphilic glycoconjugates for neurological use |
06/30/1993 | EP0548234A1 Cloning of chicken anaemia dna |
06/30/1993 | EP0548217A1 Process for the preparation of c-terminally amidated peptides. |
06/30/1993 | EP0548178A1 Quantitative analysis and monitoring of protein structure by subtractive chromatography |
06/30/1993 | EP0522073A4 Improved major histocompatibility complex (mhc) molecules |
06/30/1993 | CN1073684A Polypeptide analogues having growth hormone releasing activity |
06/30/1993 | CN1021436C Process for preparing of absolute stereochemical formula crystallographic compound |
06/29/1993 | US5223488 Oxidized-type glutathione alkyl ester |
06/29/1993 | US5223482 Polypeptide |
06/29/1993 | US5223481 Biologically active lipoprotein and its use |
06/29/1993 | US5223435 Amino acid sequence determination with mobile peptide |
06/29/1993 | US5223411 Nonionic surfactants having a carbamoyl group and process for treatment of a proteins containing medium using the same |
06/29/1993 | US5223409 Directed evolution of novel binding proteins |
06/29/1993 | US5223256 Thrombolytically active non-glycosylated protein |
06/29/1993 | CA1319787C Process for producing -l-aspartyl-l-phenylalanine methyl ester having an improved solubility |
06/24/1993 | WO1993012427A1 Automated apparatus for use in peptide synthesis |
06/24/1993 | WO1993012146A1 Trophoblast interferons and their use |
06/24/1993 | WO1993012143A1 Dimer of molecular variant of apolipoprotein and processes for the production thereof |
06/24/1993 | WO1993012142A1 Cytokines with an unpaired cysteine residue and conjugates thereof |
06/24/1993 | WO1993012076A1 Reagents for automated synthesis of peptide analogs |
06/24/1993 | WO1993011796A1 Further improvements relating to the radiolabelling of proteins |
06/24/1993 | WO1993011794A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
06/24/1993 | WO1993011781A1 Synthetic compounds and compositions with enhanced cell binding |
06/24/1993 | CA2125975A1 Further improvements relating to the radiolabelling of proteins |
06/24/1993 | CA2125181A1 Trophoblast interferons and their use |
06/24/1993 | CA2124672A1 Cytokines with an upaired cysteine residue and conjugates thereof |
06/23/1993 | EP0548012A1 Endoplastic reticulum-located recombinant dibasic endoprotease and uses thereof |
06/23/1993 | EP0547932A1 Process for preparing an activated factor VII concentrate having a high purity |
06/23/1993 | EP0547544A2 Process for the preparation of insulin-containing solutions |
06/23/1993 | EP0547446A2 Vaccines based on modified bovine herpesvirus type I |
06/23/1993 | EP0547342A1 Method for crystallization of alpha-L-aspartyl-L-phenylalanine methyl ester |
06/23/1993 | EP0547102A1 Solubilization of proteins in active forms |
06/23/1993 | EP0263172B1 Protein analogues of tissue plasminogen activator |
06/23/1993 | EP0249635B1 Word recognition in a speech recognition system using data reduced word templates |
06/22/1993 | US5221789 Interferon-gamma receptor fragment and its production |
06/22/1993 | US5221754 Reagents for rapid peptide synthesis |
06/22/1993 | US5221736 Sequential peptide and oligonucleotide syntheses using immunoaffinity techniques |
06/22/1993 | US5221734 Separation by chromatography |
06/18/1993 | EP0597845A4 GROWTH FACTOR WHICH INHIBITS THE GROWTH OF CELLS OVEREXPRESSING THE HUMAN ONCOGENE erbB-2. |
06/17/1993 | DE4141302A1 Protein irreversibly immobilised on macroporous cellulose@ beads - by reversible adsorption then crosslinking or physical inclusion, e.g. for conversion or sepn. processes |
06/16/1993 | EP0546916A1 Method for the separation of lp(a) by electrophoresis, gels for the implementation of this method and its application to the in vitro determination of atherogenic risk linked to the presence of lp(a) |
06/16/1993 | EP0546393A1 Peptide synthesizer |
06/16/1993 | EP0546127A1 Biosynthetic cerebrospinal fluid control and method of use. |
06/16/1993 | EP0546125A1 Osteogenic factor |
06/16/1993 | EP0546118A1 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis |